25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Plandai Biotech
Buy, Hold or Sell?

Let's analyze Plandai Biotech together

I guess you are interested in Plandai Biotech. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Plandai Biotech. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Plandai Biotech

I send you an email if I find something interesting about Plandai Biotech.

1. Quick Overview

1.1. Quick analysis of Plandai Biotech (30 sec.)










1.2. What can you expect buying and holding a share of Plandai Biotech? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.00
Expected worth in 1 year
$0.00
How sure are you?
37.5%

+ What do you gain per year?

Total Gains per Share
$0.00
Return On Investment
-306.2%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.0001 - $0.0002
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Plandai Biotech (5 min.)




Live pricePrice per Share (EOD)
$0.00
Intrinsic Value Per Share
$0.00 - $0.01
Total Value Per Share
$0.00 - $0.01

2.2. Growth of Plandai Biotech (5 min.)




Is Plandai Biotech growing?

Current yearPrevious yearGrowGrow %
How rich?-$55k$6.8m-$6.8m-12,496.7%

How much money is Plandai Biotech making?

Current yearPrevious yearGrowGrow %
Making money$16m-$19.8m$35.8m223.5%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Plandai Biotech (5 min.)




2.4. Comparing to competitors in the Shell Companies industry (5 min.)




  Industry Rankings (Shell Companies)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Plandai Biotech?

Welcome investor! Plandai Biotech's management wants to use your money to grow the business. In return you get a share of Plandai Biotech.

First you should know what it really means to hold a share of Plandai Biotech. And how you can make/lose money.

Speculation

The Price per Share of Plandai Biotech is $0.0002. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Plandai Biotech.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Plandai Biotech, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.00. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Plandai Biotech.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.00178.5%0.00178.5%0.00-220.6%0.005.7%0.00-21.4%
Usd Book Value Change Per Share0.00-76.6%0.00-76.6%0.0012.1%0.0033.2%0.004.9%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-76.6%0.00-76.6%0.0012.1%0.0033.2%0.004.9%
Usd Price Per Share0.00-0.00-0.00-0.00-0.03-
Price to Earnings Ratio0.84-0.84--0.91--117.46--267.85-
Price-to-Total Gains Ratio-1.96--1.96-16.57-3.20--340.20-
Price to Book Ratio-244.85--244.85-2.63--51.21--204.77-
Price-to-Total Gains Ratio-1.96--1.96-16.57-3.20--340.20-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0002
Number of shares5000000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (5000000 shares)-765.57332.00
Gains per Year (5000000 shares)-3,062.291,327.99
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-3062-3072013281318
20-6125-6134026562646
30-9187-9196039843974
40-12249-12258053125302
50-15311-15320066406630
60-18374-18382079687958
70-21436-21444092969286
80-24498-2450601062410614
90-27561-2756801195211942
100-30623-3063001328013270

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%2.01.00.066.7%2.03.00.040.0%2.06.00.025.0%2.018.00.010.0%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%3.05.00.037.5%5.014.01.025.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.08.00.0%0.00.020.00.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%3.05.00.037.5%5.014.01.025.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Plandai Biotech compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0000.0000%0.000-734%0.000-331%0.000-1678%
Book Value Per Share--0.0000.0000%0.000-101%0.000+2952%0.000+9821%
Current Ratio----0%-0%0.005-100%0.009-100%
Debt To Asset Ratio--1.5501.5500%0.061+2443%1.340+16%1.841-16%
Debt To Equity Ratio----0%-0%-0%-0%
Dividend Per Share----0%-0%-0%-0%
Eps--0.0000.0000%0.000+224%0.000+3016%0.000+112%
Free Cash Flow Per Share--0.0000.0000%0.000+2702%0.000+170%0.000+531%
Free Cash Flow To Equity Per Share--0.0000.0000%0.000-100%0.000-99%0.000-97%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--0.007--------
Intrinsic Value_10Y_min--0.002--------
Intrinsic Value_1Y_max--0.000--------
Intrinsic Value_1Y_min--0.000--------
Intrinsic Value_3Y_max--0.001--------
Intrinsic Value_3Y_min--0.000--------
Intrinsic Value_5Y_max--0.002--------
Intrinsic Value_5Y_min--0.001--------
Market Cap8977800.397-50%13466710.31113466710.3110%17955600.794-25%36808983.570-63%1552598357.336-99%
Net Profit Margin----0%-0%-0%-15.9440%
Operating Margin----0%-0%-0%-14.0000%
Operating Ratio----0%-0%-0%14.518-100%
Pb Ratio-163.233+33%-244.849-244.8490%2.633-9397%-51.212-79%-204.768-16%
Pe Ratio0.560-50%0.8400.8400%-0.907+208%-117.457+14081%-267.852+31982%
Price Per Share0.000-50%0.0000.0000%0.000-25%0.001-63%0.035-99%
Price To Free Cash Flow Ratio0.574-50%0.8610.8610%32.172-97%-1336.449+155310%-1431.783+166382%
Price To Total Gains Ratio-1.306+33%-1.959-1.9590%16.568-112%3.199-161%-340.202+17263%
Quick Ratio----0%-0%0.005-100%0.004-100%
Return On Assets--160.291160.2910%-2.727+102%31.687+406%19.505+722%
Return On Equity----0%-0%-0%-0%
Total Gains Per Share--0.0000.0000%0.000-734%0.000-331%0.000-1678%
Usd Book Value---55000.000-55000.0000%6818159.000-101%-1678835.400+2952%-5456487.375+9821%
Usd Book Value Change Per Share--0.0000.0000%0.000-734%0.000-331%0.000-1678%
Usd Book Value Per Share--0.0000.0000%0.000-101%0.000+2952%0.000+9821%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0000.0000%0.000+224%0.000+3016%0.000+112%
Usd Free Cash Flow--15639729.00015639729.0000%558112.000+2702%4631232.400+238%2169617.750+621%
Usd Free Cash Flow Per Share--0.0000.0000%0.000+2702%0.000+170%0.000+531%
Usd Free Cash Flow To Equity Per Share--0.0000.0000%0.000-100%0.000-99%0.000-97%
Usd Market Cap8977800.397-50%13466710.31113466710.3110%17955600.794-25%36808983.570-63%1552598357.336-99%
Usd Price Per Share0.000-50%0.0000.0000%0.000-25%0.001-63%0.035-99%
Usd Profit--16029051.00016029051.0000%-19800760.000+224%514411.800+3016%-1924655.125+112%
Usd Revenue----0%-0%-0%100422.625-100%
Usd Total Gains Per Share--0.0000.0000%0.000-734%0.000-331%0.000-1678%
 EOD+4 -4MRQTTM+0 -0YOY+10 -155Y+12 -1510Y+15 -14

3.3 Fundamental Score

Let's check the fundamental score of Plandai Biotech based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-150.560
Price to Book Ratio (EOD)Between0-1-163.233
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than10.000
Debt to Asset Ratio (MRQ)Less than11.550
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05160.291
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Plandai Biotech based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.783
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.000
OpenGreater thanClose0.000
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Plandai Biotech

Plandaí Biotechnology, Inc. focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries. It is developing Phytofare Catechin Complex, a botanical extract derived from green tea harvested in the Senteeko Tea Estate in Mpumalanga, South Africa; and Phytofare citrus complex, a citrus extract, as well as extracts from tomato fruit, Artemisia, and cannabis. The company also produces and sells timber and agricultural products from its farm and tea estate holdings in South Africa. Plandaí Biotechnology, Inc. is based in London, the United Kingdom.

Fundamental data was last updated by Penke on 2024-11-27 14:02:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Plandai Biotech earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Plandai Biotech to the Shell Companies industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Plandai Biotech:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-1,594.4%+1,594.4%
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ--72.5%+72.5%
TTM--6.9%+6.9%
YOY--10.4%+10.4%
5Y--8.0%+8.0%
10Y-1,594.4%-17.8%-1,576.6%
4.3.1.2. Return on Assets

Shows how efficient Plandai Biotech is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Plandai Biotech to the Shell Companies industry mean.
  • 16,029.1% Return on Assets means that Plandai Biotech generated $160.29 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Plandai Biotech:

  • The MRQ is 16,029.1%. Using its assets, the company is very efficient in making profit. +2
  • The TTM is 16,029.1%. Using its assets, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ16,029.1%TTM16,029.1%0.0%
TTM16,029.1%YOY-272.7%+16,301.8%
TTM16,029.1%5Y3,168.7%+12,860.3%
5Y3,168.7%10Y1,950.5%+1,218.2%
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ16,029.1%-1.3%+16,030.4%
TTM16,029.1%-0.9%+16,030.0%
YOY-272.7%0.2%-272.9%
5Y3,168.7%-2.8%+3,171.5%
10Y1,950.5%-2.3%+1,952.8%
4.3.1.3. Return on Equity

Shows how efficient Plandai Biotech is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Plandai Biotech to the Shell Companies industry mean.
  • 0.0% Return on Equity means Plandai Biotech generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Plandai Biotech:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ--1.0%+1.0%
TTM--0.3%+0.3%
YOY-0.6%-0.6%
5Y--1.6%+1.6%
10Y--1.9%+1.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Plandai Biotech.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Plandai Biotech is operating .

  • Measures how much profit Plandai Biotech makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Plandai Biotech to the Shell Companies industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Plandai Biotech:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-1,400.0%+1,400.0%
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ--87.7%+87.7%
TTM--27.8%+27.8%
YOY--19.9%+19.9%
5Y--12.9%+12.9%
10Y-1,400.0%-29.0%-1,371.0%
4.3.2.2. Operating Ratio

Measures how efficient Plandai Biotech is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Shell Companies industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Plandai Biotech:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y14.518-14.518
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.361-1.361
TTM-0.909-0.909
YOY-0.898-0.898
5Y-0.465-0.465
10Y14.5180.687+13.831
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Plandai Biotech.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Plandai Biotech is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Shell Companies industry mean).
  • A Current Ratio of 0.00 means the company has $0.00 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Plandai Biotech:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.005-0.005
5Y0.00510Y0.009-0.004
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.057-0.057
TTM-0.108-0.108
YOY-0.764-0.764
5Y0.0051.519-1.514
10Y0.0091.585-1.576
4.4.3.2. Quick Ratio

Measures if Plandai Biotech is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Plandai Biotech to the Shell Companies industry mean.
  • A Quick Ratio of 0.00 means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Plandai Biotech:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.005-0.005
5Y0.00510Y0.004+0.001
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.155-0.155
TTM-0.505-0.505
YOY-0.665-0.665
5Y0.0053.541-3.536
10Y0.0043.385-3.381
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Plandai Biotech.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Plandai Biotech assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Plandai Biotech to Shell Companies industry mean.
  • A Debt to Asset Ratio of 1.55 means that Plandai Biotech assets are financed with 155.0% credit (debt) and the remaining percentage (100% - 155.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Plandai Biotech:

  • The MRQ is 1.550. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.550. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.550TTM1.5500.000
TTM1.550YOY0.061+1.489
TTM1.5505Y1.340+0.210
5Y1.34010Y1.841-0.501
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5500.479+1.071
TTM1.5500.356+1.194
YOY0.0610.112-0.051
5Y1.3400.353+0.987
10Y1.8410.353+1.488
4.5.4.2. Debt to Equity Ratio

Measures if Plandai Biotech is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Plandai Biotech to the Shell Companies industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Plandai Biotech:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.417-0.417
TTM-0.297-0.297
YOY-0.087-0.087
5Y-1.176-1.176
10Y-1.135-1.135
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Plandai Biotech generates.

  • Above 15 is considered overpriced but always compare Plandai Biotech to the Shell Companies industry mean.
  • A PE ratio of 0.84 means the investor is paying $0.84 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Plandai Biotech:

  • The EOD is 0.560. Based on the earnings, the company is cheap. +2
  • The MRQ is 0.840. Based on the earnings, the company is cheap. +2
  • The TTM is 0.840. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.560MRQ0.840-0.280
MRQ0.840TTM0.8400.000
TTM0.840YOY-0.907+1.747
TTM0.8405Y-117.457+118.297
5Y-117.45710Y-267.852+150.395
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
EOD0.560-9.784+10.344
MRQ0.840-12.576+13.416
TTM0.840-7.821+8.661
YOY-0.9078.543-9.450
5Y-117.457-21.215-96.242
10Y-267.852-18.693-249.159
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Plandai Biotech:

  • The EOD is 0.574. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 0.861. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 0.861. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.574MRQ0.861-0.287
MRQ0.861TTM0.8610.000
TTM0.861YOY32.172-31.311
TTM0.8615Y-1,336.449+1,337.310
5Y-1,336.44910Y-1,431.783+95.334
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
EOD0.574-48.379+48.953
MRQ0.861-49.512+50.373
TTM0.861-67.136+67.997
YOY32.172-166.320+198.492
5Y-1,336.449-146.909-1,189.540
10Y-1,431.783-141.003-1,290.780
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Plandai Biotech is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Shell Companies industry mean).
  • A PB ratio of -244.85 means the investor is paying $-244.85 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Plandai Biotech:

  • The EOD is -163.233. Based on the equity, the company is expensive. -2
  • The MRQ is -244.849. Based on the equity, the company is expensive. -2
  • The TTM is -244.849. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-163.233MRQ-244.849+81.616
MRQ-244.849TTM-244.8490.000
TTM-244.849YOY2.633-247.483
TTM-244.8495Y-51.212-193.637
5Y-51.21210Y-204.768+153.556
Compared to industry (Shell Companies)
PeriodCompanyIndustry (mean)+/- 
EOD-163.2332.466-165.699
MRQ-244.8492.725-247.574
TTM-244.8492.554-247.403
YOY2.6331.404+1.229
5Y-51.2121.596-52.808
10Y-204.7681.596-206.364
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. All numbers in thousands.

Summary
Total Assets100
Total Liabilities155
Total Stockholder Equity-55
 As reported
Total Liabilities 155
Total Stockholder Equity+ -55
Total Assets = 100

Assets

Total Assets100
Total Current Assets0
Long-term Assets100
Total Current Assets
Total Current Assets  (as reported)0
Total Current Assets  (calculated)0
+/-0
Long-term Assets
Long-term Assets  (as reported)100
Long-term Assets  (calculated)0
+/- 100

Liabilities & Shareholders' Equity

Total Current Liabilities55
Long-term Liabilities100
Total Stockholder Equity-55
Total Current Liabilities
Short-term Debt 55
Total Current Liabilities  (as reported)55
Total Current Liabilities  (calculated)55
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)100
Long-term Liabilities  (calculated)0
+/- 100
Total Stockholder Equity
Common Stock4,489
Retained Earnings -44,023
Accumulated Other Comprehensive Income 170
Other Stockholders Equity 39,309
Total Stockholder Equity (as reported)-55
Total Stockholder Equity (calculated)-55
+/- 0
Other
Common Stock Shares Outstanding 44,889,034
Liabilities and Stockholders Equity 100
Net Debt 155
Short Long Term Debt Total 155



6.2. Balance Sheets Structured

All numbers in thousands.

 Trend2024-06-302023-06-302022-06-302021-06-302020-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-30
> Total Assets 
1,704
1,704
1,834
2,291
3,127
1,213
878
1,728
942
6,057
8,835
9,683
8,505
6,450
6,819
7,261
0
0
0
100
1000007,2616,8196,4508,5059,6838,8356,0579421,7288781,2133,1272,2911,8341,7041,704
   > Total Current Assets 
1,343
1,343
1,446
1,964
2,905
1,061
856
1,447
672
27
519
594
418
185
183
574
0
0
0
0
0000574183185418594519276721,4478561,0612,9051,9641,4461,3431,343
       Cash And Cash Equivalents 
-2
-2
-28
-18
-6
21
7
7
0
5
499
157
34
13
7
0
0
0
0
0
0000071334157499507721-6-18-28-2-2
       Short-term Investments 
0
0
0
0
1,321
44
62
22
0
0
0
0
0
0
0
0
0
0
0
0
0000000000002262441,3210000
       Net Receivables 
1,272
1,272
1,282
1,654
1,261
795
634
1,183
574
0
14
435
17
41
41
574
0
0
0
0
00005744141174351405741,1836347951,2611,6541,2821,2721,272
       Inventory 
70
70
164
170
122
172
135
231
95
0
6
3
2
66
59
0
0
0
0
0
0000059662360952311351721221701647070
       Other Current Assets 
2
2
28
158
202
29
17
3
2
0
0
96
365
0
76
0
0
0
0
0
0000076036596002317292021582822
   > Long-term Assets 
361
361
388
327
222
152
22
281
271
6,030
8,316
9,090
8,086
6,265
6,636
6,687
0
0
0
100
1000006,6876,6366,2658,0869,0908,3166,03027128122152222327388361361
       Property Plant Equipment 
349
349
366
309
218
149
22
281
271
216
7,925
8,856
8,010
6,082
6,418
6,687
0
0
0
0
00006,6876,4186,0828,0108,8567,92521627128122149218309366349349
       Long-term Assets Other 
12
12
22
18
3
3
0
0
0
5,814
392
234
76
65
78
0
0
0
0
0
000007865762343925,8140003318221212
> Total Liabilities 
2,576
2,576
3,934
4,543
4,116
4,246
4,575
6,229
6,001
6,347
12,320
13,223
16,821
18,433
21,777
26,239
9,174
1,526
443
155
1554431,5269,17426,23921,77718,43316,82113,22312,3206,3476,0016,2294,5754,2464,1164,5433,9342,5762,576
   > Total Current Liabilities 
2,574
2,574
3,183
3,495
2,330
2,044
2,124
6,229
6,001
100
904
227
15,147
16,774
19,609
23,588
9,174
1,526
443
55
554431,5269,17423,58819,60916,77415,1472279041006,0016,2292,1242,0442,3303,4953,1832,5742,574
       Short-term Debt 
1,530
1,530
1,926
1,976
1,442
819
380
428
0
6,839
104
18
14,526
14,285
17,044
19,037
7,031
115
50
55
55501157,03119,03717,04414,28514,526181046,83904283808191,4421,9761,9261,5301,530
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
6,839
11,520
3,033
14,526
14,285
17,594
0
0
115
50
0
0501150017,59414,28514,5263,03311,5206,839000000000
       Accounts payable 
1,025
1,025
1,257
1,519
888
1,225
1,745
1,874
1,936
64
516
3
316
725
812
1,363
271
296
330
0
03302962711,3638127253163516641,9361,8741,7451,2258881,5191,2571,0251,025
       Other Current Liabilities 
19
19
0
0
0
0
0
3,926
4,065
36
45
24
305
1,022
1,752
3,188
1,872
1,116
62
0
0621,1161,8723,1881,7521,0223052445364,0653,926000001919
   > Long-term Liabilities 
2
2
750
1,048
1,786
2,202
2,450
0
0
6,246
11,416
12,996
1,674
1,659
2,168
2,651
0
0
0
100
1000002,6512,1681,6591,67412,99611,4166,246002,4502,2021,7861,04875022
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
160
132
2,118
0
0
0
0
0
000002,118132160000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
1,527
0
0
0
0
0
0
0000001,5270000000000000
> Total Stockholder Equity
-872
-872
-2,099
-2,252
-989
-3,033
-3,697
-4,501
-5,058
-225
-2,628
-2,203
-6,499
-9,804
-13,369
-16,928
-9,174
-1,526
-443
-55
-55-443-1,526-9,174-16,928-13,369-9,804-6,499-2,203-2,628-225-5,058-4,501-3,697-3,033-989-2,252-2,099-872-872
   Common Stock
6
6
6
6
7
6
1
1
1
11
11
13
16
19
26
94
496
701
820
4,489
4,48982070149694261916131111111676666
   Retained Earnings -44,023-60,047-40,246-47,070-51,256-44,696-40,688-36,309-25,957-10,904-8,135-9,535-8,987-7,565-6,739-4,845-3,866-3,269-1,750-1,750
   Capital Surplus 00000000000000000000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 
872
872
964
1,117
3,937
3,699
3,867
4,485
4,475
7,894
8,096
23,427
30,170
30,853
32,301
36,157
39,322
38,019
58,785
39,309
39,30958,78538,01939,32236,15732,30130,85330,17023,4278,0967,8944,4754,4853,8673,6993,9371,117964872872



6.3. Balance Sheets

All numbers in thousands.




6.4. Cash Flows

All numbers in thousands.




6.5. Income Statements

All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-06-30. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-3,811
Operating Income-3,811-3,811
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense3,8110
 
Net Interest Income (+$)
Interest Income0
Interest Expense-5
Other Finance Cost-5
Net Interest Income0
 
Pretax Income (+$)
Operating Income-3,811
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)16,029-23,651
EBIT - interestExpense = -3,816
32,058
16,034
Interest Expense5
Earnings Before Interest and Taxes (EBIT)-3,81116,034
Earnings Before Interest and Taxes (EBITDA)16,034
 
After tax Income (+$)
Income Before Tax16,029
Tax Provision-0
Net Income From Continuing Ops016,029
Net Income16,029
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses3,811
Total Other Income/Expenses Net19,8400
 

Technical Analysis of Plandai Biotech
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Plandai Biotech. The general trend of Plandai Biotech is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Plandai Biotech's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Plandai Biotech.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.0002 < 0.0002 < 0.0002.

The bearish price targets are: 0.0001 > 0.0001 > 0.0001.

Tweet this
Plandai Biotech Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Plandai Biotech. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Plandai Biotech Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Plandai Biotech. The current macd is 0.0000.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Plandai Biotech price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Plandai Biotech. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Plandai Biotech price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Plandai Biotech Daily Moving Average Convergence/Divergence (MACD) ChartPlandai Biotech Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Plandai Biotech. The current adx is 36.32.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Plandai Biotech shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Plandai Biotech Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Plandai Biotech. The current sar is 0.00021132.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Plandai Biotech Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Plandai Biotech. The current rsi is 53.78. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Plandai Biotech Daily Relative Strength Index (RSI) ChartPlandai Biotech Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Plandai Biotech. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Plandai Biotech price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Plandai Biotech Daily Stochastic Oscillator ChartPlandai Biotech Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Plandai Biotech. The current cci is 56.41.

Plandai Biotech Daily Commodity Channel Index (CCI) ChartPlandai Biotech Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Plandai Biotech. The current cmo is 12.75.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Plandai Biotech Daily Chande Momentum Oscillator (CMO) ChartPlandai Biotech Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Plandai Biotech. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Plandai Biotech Daily Williams %R ChartPlandai Biotech Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Plandai Biotech.

Plandai Biotech Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Plandai Biotech. The current atr is 0.00009.

Plandai Biotech Daily Average True Range (ATR) ChartPlandai Biotech Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Plandai Biotech. The current obv is 4,755,026,435.

Plandai Biotech Daily On-Balance Volume (OBV) ChartPlandai Biotech Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Plandai Biotech. The current mfi is 62.89.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Plandai Biotech Daily Money Flow Index (MFI) ChartPlandai Biotech Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Plandai Biotech.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-12MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-15MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-07-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-08-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-09-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-09-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-09-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-23CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-31STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-04MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Plandai Biotech Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Plandai Biotech based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.783
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.000
OpenGreater thanClose0.000
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Plandai Biotech with someone you think should read this too:
  • Are you bullish or bearish on Plandai Biotech? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Plandai Biotech? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Plandai Biotech

I send you an email if I find something interesting about Plandai Biotech.


Comments

How you think about this?

Leave a comment

Stay informed about Plandai Biotech.

Receive notifications about Plandai Biotech in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.